Estimating the incidence and mortality of cancer in Colombia: What are the best data for public policies?
Article Sidebar
Main Article Content
Colombia simultaneously faces the challenge of controlling both the communicable and non-communicable diseases. Information provided by the population-based cancer registries (PBCRs) of Colombia1-4 indicates that cancer is a major cause of morbidity in our region. Based on the information provided by the PBCRs of Colombia and taking into account mortality data from cancer, the Colombian National Cancer Institute (NCI) estimates that, in Colombia, there are about 63,000 new cases and 33,000 deaths by cancer each year5. The number of people living with the disease is unknown.The possibility of reducing cancer mortality and preventing 30% of malignancies has encouraged the Colombian government to design a Cancer National Information System (Cancer-NIS)6 and to formulate a ten-year plan for its control7.
Having good quality statistics on the cancer burden is essential to make an accurate diagnostic of the cancer problem and to design, implement and monitor control measures. Otherwise, the human, social and economic costs produced by this group of diseases will continue to increase, and they will exceed the country’s capacity to fight them.
Yépez MC, Bravo LE, Hidalgo-Troya A, Jurado DM, Bravo LM. Cancer incidence and mortality in the municipality of Pasto, 1998 – 2007. Colomb Med (Cali). 2012 Dec 30;43(4):256-66.
Uribe C, Osma S, Herrera V. Cancer incidence and mortality in the Bucaramanga metropolitan area, 2003-2007. Colomb Med (Cali). 2012 Dec 30;43(4):290-7.
López Guarnizo G, Arias Ortiz N, Arboleda Ruiz W. Cancer incidence and mortality in Manizales 2003-2007. Colomb Med (Cali). 2012 Dec 30;43(4):281-9.
Bravo LE, Collazos T, Collazos P, García LS, Correa P. Trends of cancer incidence and mortality in Cali, Colombia. 50 years experience. Colomb Med (Cali). 2012 Dec 30;43(4):246-55.
Pardo C, Cendales R. Incidencia, mortalidad y prevalencia de cáncer en Colombia, 2007-2011. Primera edición. Bogotá. D.C: Instituto Nacional de Cancerología, 2015, v.1.
Ospina ML, Huertas JA, Montaño JI, Rivillas JC. Observatorio Nacional de Cáncer Colombia. Rev. Fac. Nac. Salud Pública. 2015; 33(2):
Ministerio de Salud y Protección Social e Instituto Nacional de Cancerología. Plan decenal para el control del cáncer en Colombia. Bogotá: Imprenta Nacional de Colombia; 2011.
Alvis LF, Acuña-Merchán L, Sánchez-Quintero P. Información preliminar sobre el reporte de cáncer y el proceso de atención en Colombia, 1. Bogotá: Cuenta de Alto Costo. Boletín de información técnica especializada Especial Cáncer; 2015, 4.
Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R and Ferlay J, editors (2014). Cancer Incidence in Five Continents, Vol. X.
IARC Scientific Publication No. 164. Lyon: International Agency for Research on Cancer.
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013 [Available from: http://globocan.iarc.fr.
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015 Mar 14;385(9972):977-1010.
Downloads
- Rodrigo Guerrero, Luis Eduardo Bravo, Edgar Muñoz, Elvia Karina Grillo Ardila, Esteban Guerrero, COVID-19: The Ivermectin African Enigma , Colombia Medica: Vol. 51 No. 4 (2020): Damage Control Surgery (I)
- Luis Eduardo Bravo, Armando Cortés, Edwin Carrascal, Roberto Jaramillo, Luz Stella García, Paco Eduardo Bravo, Aníbal Badel, Pablo Andrés Bravo, Helicobacter pylori: patología y prevalencia en biopsias gástricas en Colombia. , Colombia Medica: Vol. 34 No. 3 (2003)
- Luis Eduardo Bravo, Nubia Muñoz, Epidemiology of cancer in Colombia , Colombia Medica: Vol. 49 No. 1 (2018): Colombia Cancer Epidemiology
- Luis Eduardo Bravo, Luz Stella Garcia, Paola Collazos, Edwin Carrascal, Elvia Karina Grillo-Ardila, Erquinovaldo Millan, Jorge Holguín, Cancer epidemiology in Cali, 60 years of experience , Colombia Medica: Vol. 53 No. 1 (2022): Cancer incidence and mortality
- Luis Eduardo Bravo, Luz Stella García, Paola Collazos, Edwin Carrascal, Oscar Ramírez, Armando Cortés, Marcela Nuñez, Erquinovaldo Millán, Reliable information for cancer control in Cali, Colombia , Colombia Medica: Vol. 49 No. 1 (2018): Colombia Cancer Epidemiology
- Luz Stella Garcia, Luis Eduardo Bravo, Paola Collazos, Oscar Ramirez, Edwin Carrascal, Marcela Nuñez, Nelson Portilla, Erquinovaldo Millan, Cali Cancer Registry Methods , Colombia Medica: Vol. 49 No. 1 (2018): Colombia Cancer Epidemiology
- Armando Cortés, Lina María Isaza, Luis Eduardo Bravo, María Fernanda Palomino, Incidencia de seroconversión para infecciones virales trasmisibles por transfusión en donantes habituales de sangre en Cali. , Colombia Medica: Vol. 32 No. 4 (2001)
- Luis Eduardo Bravo, Luz Stella Garcia, Paola Collazos, Jorge Alirio Holguin, Isabelle Soerjomataram, Adalberto Miranda-Filho, Trends in long-term cancer survival in Cali, Colombia: 1998-2017 , Colombia Medica: Vol. 53 No. 1 (2022): Cancer incidence and mortality
- Rodrigo Guerrero, Luis Eduardo Bravo, Edgar Muñoz, Elvia Karina Grillo Ardila, Esteban Guerrero, Reply to a letter from Robert Colebunders entitled COVID-19: The African Enigma , Colombia Medica: Vol. 52 No. 2 (2021): Damage Control Surgery (II)
- Carlos Reina, Miyerlandi Torres, Edgar Muñoz, Elvia Karina Grillo Ardila, Rodrigo Guerrero, Luis Eduardo Bravo, Mortality due to COVID-19 during the vaccination plan against the SARS-CoV-2 virus in Cali, Colombia , Colombia Medica: Vol. 52 No. 4 (2021)
Accepted 2016-06-30
Published 2016-06-30
Similar Articles
- Luis Eduardo Bravo, Luz Stella Garcia, Paola Collazos, Edwin Carrascal, Elvia Karina Grillo-Ardila, Erquinovaldo Millan, Jorge Holguín, Cancer epidemiology in Cali, 60 years of experience , Colombia Medica: Vol. 53 No. 1 (2022): Cancer incidence and mortality
- Mariela Garau, Rafael Alonso, Carina Musetti, Enrique Barrios, Cancer incidence and mortality in Uruguay: 2013-2017 , Colombia Medica: Vol. 53 No. 1 (2022): Cancer incidence and mortality
- Luis Eduardo Bravo Ocaña, Paola Collazos, Elvia Karina Grillo Ardila, Luz Stella García, Erquinovaldo Millán, Patricia Mera, Jorge Holguín, Mortality from respiratory infections and chronic non-communicable diseases before the COVID-19 pandemic in Cali, Colombia. , Colombia Medica: Vol. 51 No. 2 (2020): Coronavirus disease 2019
- Anderson Rocha-Buelvas, Elizabeth Trujillo-Montalvo, Carlos Alberto Hidalgo-Patiño, Ángela Hidalgo-Eraso, Burden of disease in Nariño, Colombia, 2010 , Colombia Medica: Vol. 45 No. 3 (2014)
- Elvia Karina Grillo Ardila, Luis Eduardo Bravo Ocaña, Rodrigo Guerrero, Julián Santaella-Tenorio, Mathematical models and the coronavirus, COVID-19 , Colombia Medica: Vol. 51 No. 2 (2020): Coronavirus disease 2019
You may also start an advanced similarity search for this article.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use